Key result
Catheter ablation links to ~15% lower absolute mortality versus medical therapy in AF and DCM.
Why the study?
Studies evaluating the long-term outcomes of catheter ablation in patients with atrial fibrillation and dilated cardiomyopathy are limited.
Does catheter ablation improve survival and reduce heart failure hospitalization in patients with atrial fibrillation and dilated cardiomyopathy compared to medical therapy?
Cohort (n=343)
No
Does catheter ablation improve survival and reduce heart failure hospitalization in patients with atrial fibrillation and dilated cardiomyopathy compared to medical therapy?
Catheter ablation provides significant long-term survival benefits, reduces heart failure hospitalizations, and reverses structural remodeling in patients with concomitant atrial fibrillation and dilated cardiomyopathy compared to medical therapy alone.
Answers are grounded in this paper and cite their sources.
Observed mortality reduction should not yet change practice; leaves open randomized confirmation in AF with dilated cardiomyopathy.
Introduction: Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. This study aimed to assess the electrophysiological characteristics of atrial fibrillation patients with dilated cardiomyopathy and compare the long-term clinical outcomes between patients undergoing catheter ablation and medical therapy. Method: Patient baseline characteristics and electrophysiological parameters were examined to identify the predictors of atrial fibrillation recurrence following catheter ablation. The clinical outcomes of catheter ablation and medical therapy were compared using the propensity score matched method. Results: = 14) after an average follow-up duration of 7.7 years following catheter ablation. The only predictive factor for atrial fibrillation recurrence after catheter ablation was the left atrial diameter. When compared to medical therapy, catheter ablation demonstrated significantly better outcomes in terms of overall survival, freedom from heart failure hospitalization, improvement in left ventricular ejection fraction, and a greater reduction in left ventricular diameter and left atrial diameter after propensity score matching. Conclusions: Therefore, catheter ablation proves to be effective in providing long-term control of atrial fibrillation in patients with dilated cardiomyopathy. In addition to standard heart failure care, catheter ablation significantly enhanced both morbidity and mortality outcomes and reversed structural remodeling when compared to heart failure medication alone.
No takes yet. Share an insight, caveat, or question.
Siow et al. (2024) conducted a cohort in Atrial fibrillation and dilated cardiomyopathy (n=343). Catheter ablation vs. Medical therapy was evaluated on All-cause mortality (after propensity score matching) (p=0.025). Catheter ablation reduced all-cause mortality compared to medical therapy in patients with atrial fibrillation and dilated cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: